NEWNow you can take heed to Fox Information articles!
Former Republican New York Metropolis mayoral candidate Curtis Sliwa sounded off Tuesday after a gunman opened hearth in a crowded subway automobile alongside the D, N and R strains in Sundown Park, Brooklyn earlier within the day.
Sliwa, founding father of the Guardian Angels, a volunteer group of residents who’ve a historical past of patrolling the subways and different drawback spots within the metropolis, instructed Fox Information that the day’s occasions and the town authorities’s continued refusal to completely help legislation enforcement and difficult legal justice insurance policies will solely exacerbate the southbound flight.
Sliwa, who grew up within the Canarsie part of Brooklyn, a number of miles east of the place the taking pictures occurred, mentioned the NYPD remains to be working with $1 billion fewer in assets than it was previous to the Defund the Police motion’s rise.
“We by no means have been in a position to get the cops again that we so desperately want, when this maniac attacked these folks,” he mentioned.
Advertisement
NYC SUBWAY SHOOTING: LIVE UPDATES
Curtis Sliwa (REUTERS/Mike Segar) ( )
“And bear in mind he had a Glock and he fired three pictures after letting out canisters of fuel in a crowded, closed prepare as folks scramble for his or her lives,” he added, calling commuting on the MTA’s underground community “like crawling into the stomach of the beast every day” amid the crime spike.
He famous that the thirty sixth Avenue station is the convergence of three essential strains – operating from Coney Island, Bay Ridge and Gravesend, all north into Manhattan.
Sliwa mentioned a station of that significance and dimension ought to have reliably working surveillance cameras, which have been reportedly inoperable when the taking pictures occurred.
Advertisement
NJ REPUBLICAN RIPS DEMOCRATS OVER PROPOSED GENDER STUDIES CURRICULUM
“[The MTA] is a system that’s falling into the abyss, and the politicians simply maintain biking – crime within the subways as much as one hundred pc. You have to take {the handcuffs} off the police, flood the system – do cease and frisk, and return some civility to the subway system,” he mentioned.
“For those who do not, New York Metropolis won’t ever get well — and extra residents can be fleeing to Florida and Georgia, North Carolina and Tennessee,” he mentioned.
Fox Information additional reported that police in New York and Philadelphia are searching for a “particular person of curiosity” recognized as 62-year-old Frank James.
A U-Haul truck reportedly linked to James was discovered to have an handle on it from a facility close to the Looking Park neighborhood of Northwest Philadelphia, reviews mentioned late Tuesday.
In Massachusetts, the spotted lanternfly, an invasive species, has been detected in several areas including Springfield, West Springfield, Wilbraham, Ludlow, Chicopee, Holyoke, and parts of Mount Tom State Reservation near South Hadley and Easthampton. This pest, which feeds on over 100 plant species by piercing and sucking out the sap, poses a threat to agriculture and native trees. Originating from Vietnam and China, it was first identified in the United States in Pennsylvania in 2014 and has since been confirmed in 16 states.
UMass Extension Entomologist Tawny Simisky highlighted the minimal current impact on Hampshire County’s agricultural sector but emphasized vigilance due to the potential threat to breweries, wineries, and orchards. The Massachusetts Department of Agricultural Resources has been monitoring the spread, encouraging residents to report sightings to aid in tracking and management efforts.
Advertisement
The invasive species is known for its preference for the tree of heaven, another invasive plant, although it can complete its life cycle without it. The spotted lanternfly breeds in late summer, leaving egg masses on various surfaces. Residents are urged to report sightings to the Massachusetts Department of Agricultural Resources and can employ nonchemical methods like sticky traps for control, reserving chemical treatments for severe infestations.
Firefighters extinguished a house fire in Manchester, New Hampshire, on Thursday night.
Manchester fire said they were called to a report of a building fire on Straw Road just before 8 p.m. Thursday. Upon arrival, they found a single-family home with extremely heavy fire coming from the entire left side of the building.
The fire had self-vented and was coming out the side and rear of the house about 35 feet above the roof, according to fire officials.
The house had an extremely steep and narrow driveway, which made it difficult for firefighters to access the building. One engine made it up the driveway and firefighters began attacking the blaze, first from the exterior and then by pushing into the building.
Advertisement
The roof was ultimately opened for ventilation, and firefighters were able to extinguish the fire. All companies cleared the scene around 11 p.m.
No injuries were reported.
The cause of the fire remains under investigation. Fire officials estimated the total damages at about $275,000.
PRINCETON, NJ, Oct. 04, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it has received preliminary approval for a tax credit from the New Jersey Technology Business Tax Certificate Transfer Program administered by the New Jersey Economic Development Authority (NJEDA). Sonnet received approval of its application to sell up to $8,143,144 of its New Jersey State net operating losses (NOLs) and $62,810 of its New Jersey State research and development (R&D) tax credits for proceeds of up to $0.795 million through the New Jersey Technology Business Tax Certificate Transfer Program, subject to execution of such sale. Sonnet also expects to receive a $0.7 million net cash refund from the R&D Tax Incentive Program in Australia.
Pankaj Mohan, Founder and Chief Executive Officer of Sonnet commented, “We are grateful for NJEDA’s continued support of the biotechnology industry and to be one of the recipients to benefit from the New Jersey Technology Business Tax Certificate Transfer Program. With the addition of the net cash refund from the Australian R&D Tax Incentive Program, this will provide Sonnet with non-dilutive capital to continue to direct our resources towards advancing our pipeline of targeted immunotherapeutic drugs.”
The Technology Business Tax Certificate Transfer Program administered by the NJEDA enables qualified companies to sell up to $20 million of their unused New Jersey NOLs and R&D tax credits to unaffiliated, profit-generating corporate taxpayers in the State of New Jersey. The Technology Business Tax Certificate Transfer Program is designed to allow technology and biotechnology companies with NOLs to turn their tax losses and credits into cash proceeds to fund more R&D, expand its workforce and cover other allowable expenditures. Sonnet is one of several biotechnology/technology companies to qualify in this competitive process to share in the funding this year.
The Australian R&D Tax Incentive Program allows certain companies to claim a significant percentage of their costs related to R&D activities they have or are planning to undertake in Australia.
Advertisement
The Company expects to receive the Australian net cash refund before calendar year end 2024 and the proceeds from the sale of its New Jersey NOLs and R&D tax credits before the end of the first calendar quarter of 2025, subject to execution of such sale.
About Sonnet BioTherapeutics Holdings, Inc.
Sonnet is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Sonnet’s FHAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. FHAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.
Forward-Looking Statements
Advertisement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the proceeds from the Company’s New Jersey State NOLs and R&D tax credits, the Company’s Australia net cash refund, the outcome of the Company’s clinical trials, the Company’s cash runway, the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.
These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Investor Relations Contact: JTC Team, LLC Jenene Thomas 908.824.0775 SONN@jtcir.com
/cdn.vox-cdn.com/uploads/chorus_asset/file/25439572/VRG_TEC_Textless.jpg "Charter will offer Peacock for free with some cable subscriptions next year")
